Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs. Anti-inflammatory Mouthwash in Oral Lichen Planus
NCT04718311Completed
- Sponsor
- University of Catania
- Start
- Jan 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Tacrolimus Ointment 0.1% Iwaki in oral lichen planus (OLP) (2 arms), sponsored by University of Catania. Primary endpoint: Clinical Mucosal healing at 180 days. Started Jan 2019; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT04718311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04718311.